Kanaph Therapeutics Inc. (KOSDAQ:0082N0)
South Korea · Delayed Price · Currency is KRW 21,300
-1,000 (-4.48%)
At close: Jun 5, 2026
Kanaph Therapeutics Market Cap
Kanaph Therapeutics has a market cap or net worth of 278.88 billion as of June 8, 2026.
Market Cap
278.88B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
21,300.00
Market Cap Chart
Since March 16, 2026, Kanaph Therapeutics's market cap has decreased from 655.58B to 278.88B, a decrease of -57.46%. That is a compound annual growth rate of -97.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 278.88B | -4.48% |
| Jun 4, 2026 | 291.97B | 1.59% |
| Jun 2, 2026 | 287.39B | -4.57% |
| Jun 1, 2026 | 301.14B | -7.07% |
| May 29, 2026 | 324.05B | -6.78% |
| May 28, 2026 | 347.62B | -3.63% |
| May 27, 2026 | 360.71B | -3.33% |
| May 26, 2026 | 373.15B | 0.35% |
| May 22, 2026 | 371.84B | 11.37% |
| May 21, 2026 | 333.87B | 1.59% |
| May 20, 2026 | 328.63B | -4.20% |
| May 19, 2026 | 343.03B | -2.60% |
| May 18, 2026 | 352.20B | -4.10% |
| May 15, 2026 | 367.26B | -6.97% |
| May 14, 2026 | 394.75B | 8.26% |
| May 13, 2026 | 364.64B | -6.86% |
| May 12, 2026 | 391.48B | 3.28% |
| May 11, 2026 | 379.04B | -8.39% |
| May 8, 2026 | 413.74B | -3.51% |
| May 7, 2026 | 428.79B | -0.30% |
| May 6, 2026 | 430.10B | -5.33% |
| May 4, 2026 | 454.32B | -4.14% |
| Apr 30, 2026 | 473.96B | -5.97% |
| Apr 29, 2026 | 504.08B | 1.32% |
| Apr 28, 2026 | 497.53B | -3.80% |
| Apr 27, 2026 | 517.17B | 4.91% |
| Apr 24, 2026 | 492.95B | 2.59% |
| Apr 23, 2026 | 480.51B | -0.54% |
| Apr 22, 2026 | 483.13B | 1.23% |
| Apr 21, 2026 | 477.24B | -4.46% |
| Apr 20, 2026 | 499.50B | 0.93% |
| Apr 17, 2026 | 494.91B | -2.83% |
| Apr 16, 2026 | 509.31B | -1.77% |
| Apr 15, 2026 | 518.48B | -1.49% |
| Apr 14, 2026 | 526.34B | -1.95% |
| Apr 13, 2026 | 536.81B | 9.92% |
| Apr 10, 2026 | 488.37B | 4.92% |
| Apr 9, 2026 | 465.45B | -0.21% |
| Apr 8, 2026 | 466.42B | 8.27% |
| Apr 7, 2026 | 430.79B | -2.49% |
| Apr 6, 2026 | 441.80B | -6.06% |
| Apr 3, 2026 | 470.30B | -2.55% |
| Apr 2, 2026 | 482.61B | -9.59% |
| Apr 1, 2026 | 533.79B | 11.05% |
| Mar 31, 2026 | 480.67B | -11.46% |
| Mar 30, 2026 | 542.86B | -9.41% |
| Mar 27, 2026 | 599.22B | 3.58% |
| Mar 26, 2026 | 578.49B | 13.90% |
| Mar 25, 2026 | 507.88B | -2.24% |
| Mar 24, 2026 | 519.54B | -7.18% |
| Mar 23, 2026 | 559.70B | -17.24% |
| Mar 20, 2026 | 676.30B | 14.98% |
| Mar 19, 2026 | 588.20B | -2.26% |
| Mar 18, 2026 | 601.81B | 1.64% |
| Mar 17, 2026 | 592.09B | -9.68% |
| Mar 16, 2026 | 655.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IMBiologics | 411.55B |
| HansBiomed | 405.74B |
| IntoCell | 379.30B |
| S.Biomedics | 378.98B |
| curacle co.,ltd. | 283.34B |
| Kangstem Biotech | 247.83B |
| Y-Biologics | 225.39B |
| NIBEC | 221.56B |